Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infections


Por: Rojo-Marcos G, Rubio-Muñoz JM, Angheben A, Jaureguiberry S, García-Bujalance S, Tomasoni LR, Rodríguez-Valero N, Ruiz-Giardín JM, Salas-Coronas J, Cuadros-González J, García-Rodríguez M, Molina-Romero I, López-Vélez R, Gobbi F, Calderón-Moreno M, Martin-Echevarría E, Elía-López M, Llovo-Taboada J, TropNet Plasmodium ovale investigator group

Publicada: 30 oct 2018
Resumen:
BackgroundFew previous retrospective studies suggest that Plasmodium ovale wallikeri seems to have a longer latency period and produces deeper thrombocytopaenia than Plasmodium ovale curtisi. Prospective studies were warranted to better assess interspecies differences.MethodsPatients with imported P. ovale spp. infection diagnosed by thick or thin film, rapid diagnostic test (RDT) or polymerase chain reaction (PCR) were recruited between March 2014 and May 2017. All were confirmed by DNA isolation and classified as P. o. curtisi or P. o. wallikeri using partial sequencing of the ssrRNA gene. Epidemiological, analytical and clinical differences were analysed by statistical methods.ResultsA total of 79 samples (35 P. o. curtisi and 44 P. o. wallikeri) were correctly genotyped. Males predominate in wallikeri group (72.7%), whereas were 48.6% in curtisi group. Conversely, 74.3% of curtisi group were from patients of African ethnicity, whilst 52.3% of Caucasians were infected by P. o. wallikeri. After performing a multivariate analysis, more thrombocytopaenic patients (p=0.022), a lower number of platelets (p=0.015), a higher INR value (p=0.041), and shorter latency in Caucasians (p=0.034) were significantly seen in P. o. wallikeri. RDT sensitivity was 26.1% in P. o. curtisi and 42.4% in P. o. wallikeri. Nearly 20% of both species were diagnosed only by PCR. Total bilirubin over 3mg/dL was found in three wallikeri cases. Two patients with curtisi infection had haemoglobin under 7g/dL, one of them also with icterus. A wallikeri patient suffered from haemophagocytosis. Chemoprophylaxis failed in 14.8% and 35% of curtisi and wallikeri patients, respectively. All treated patients with various anti-malarials which included artesunate recovered. Diabetes mellitus was described in 5 patients (6.32%), 4 patients of wallikeri group and 1 curtisi.ConclusionsImported P. o. wallikeri infection may be more frequent in males and Caucasians. Malaria caused by P. o. wallikeri produces more thrombocytopaenia, a higher INR and shorter latency in Caucasians and suggests a more pathogenic species. Severe cases can be seen in both species. Chemoprophylaxis seems less effective in P. ovale spp. infection than in P. falciparum, but any anti-malarial drug is effective as initial treatment. Diabetes mellitus could be a risk factor for P. ovale spp. infection.

Filiaciones:
Rojo-Marcos G:
 Hospital Universitario Príncipe de Asturias, Ctra de Meco s/n, 28805, Alcalá de Henares, Madrid, Spain.

Rubio-Muñoz JM:
 Instituto de Salud Carlos III, Majadahonda, Madrid, Spain

Angheben A:
 Ospedale Sacro Cuore - Don Calabria, Negrar, Verona, Italy

Jaureguiberry S:
 Hôpital Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France

García-Bujalance S:
 Hospital Universitario La Paz-Carlos III, Madrid, Spain

Tomasoni LR:
 Spedali Civili Hospital, University of Brescia, Brescia, Italy

Rodríguez-Valero N:
 Hospital Clinic, Barcelona, Spain

Ruiz-Giardín JM:
 Hospital Universitario de Fuenlabrada, Madrid, Spain

Salas-Coronas J:
 Hospital del Poniente-El Ejido, Almería, Spain

Cuadros-González J:
 Hospital Universitario Príncipe de Asturias, Ctra de Meco s/n, 28805, Alcalá de Henares, Madrid, Spain

García-Rodríguez M:
 Hospital General Universitario de Valencia, Valencia, Spain

Molina-Romero I:
 Hospital Vall D´Hebron-Drassanes, Barcelona, Spain

López-Vélez R:
 Hospital Universitario Ramon y Cajal, Madrid, Spain

Gobbi F:
 Ospedale Sacro Cuore - Don Calabria, Negrar, Verona, Italy

Calderón-Moreno M:
 Hospital Universitario Gregorio Marañón, Madrid, Spain

Martin-Echevarría E:
 Hospital Universitario de Guadalajara, Guadalajara, Spain

Elía-López M:
 Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain

Llovo-Taboada J:
 Complejo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain
ISSN: 14752875





MALARIA JOURNAL
Editorial
BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 17 Número: 1
Páginas: 399-399
WOS Id: 000448841900002
ID de PubMed: 30376868

MÉTRICAS